ISZO CAPITAL MANAGEMENT LP
Follow13F filer, CIK 1607925, NEW YORK, NY
ISZO CAPITAL MANAGEMENT LP reported $7,479,907 across 7 holdings for the quarter ended 2022-12-31, in a 13F-HR filed 2023-02-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001013594-23-000255
- Period
- 2022-12-31
- Reported value
- $7.48M
- Holdings
- 7
- Top 10 weight
- 100%
- New
- 2
- Sold out
- 1
Part of the filer group ISZO CAPITAL LP
ISZO CAPITAL LPBrian L. Sheehy
- ISZO CAPITAL LP
- Brian L. Sheehy
- IsZo Capital GP LLC
Stakes and trades reported after 2022-12-31
13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.
- LQDA LIQUIDIA CORPORATION: 13G 4,712,900 shares, 5.2% of the class, 13G filed 2026-11-19, 0001013594-26-001217Timeline
Accepted , ingested
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| CVNAnew | +150,000 | $711K |
| AMPYnew | +953 | $8.38K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| NTPIFexited | -6,918,372 | -$29.2M |
| LFCRreduced | -1,156,874 | -$7.5M |
| LNTHreduced | -119,173 | -$6.07M |
| CBLreduced | -54,000 | -$1.25M |
| CCELreduced | -83,842 | -$355K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q4 2022
Share positions as resolved from 13F-HR 0001013594-23-000255, largest first. % of portfolio is the value over $7,479,906, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| LFCRLIFECORE BIOMEDICAL INC | 373,778 | $2.42M | 32.38% | -1,156,874 | Timeline | ||
| CBLCBL & ASSOC PPTYS INC | 78,316 | $1.81M | 24.17% | -54,000 | Timeline | ||
| LNTHLANTHEUS HLDGS INC | 17,077 | $870K | 11.63% | -119,173 | Timeline | ||
| CORBFGLOBAL CORD BLOOD CORP | 279,495 | $836K | 11.17% | 0 | Timeline | ||
| CCELCRYO-CELL INTL INC | 195,031 | $825K | 11.03% | -83,842 | Timeline | ||
| CVNACARVANA CO | 150,000 | $711K | 9.51% | new | Timeline | ||
| AMPYAMPLIFY ENERGY CORP NEW | 953 | $8.38K | 0.11% | new | Timeline |
Sold out in Q4 2022
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| NTPIFNAM TAI PROPERTY INC | 6,918,372 | $29.2M | shares |
How Q4 2022 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001013594-23-000255 | base | 2023-02-14 | acceptance time not in the bulk data set |